132 related articles for article (PubMed ID: 32971853)
1. Glycoproteomic Analysis Reveals Aberrant Expression of Complement C9 and Fibronectin in the Plasma of Patients with Colorectal Cancer.
Chantaraamporn J; Champattanachai V; Khongmanee A; Verathamjamras C; Prasongsook N; Mingkwan K; Luevisadpibul V; Chutipongtanate S; Svasti J
Proteomes; 2020 Sep; 8(3):. PubMed ID: 32971853
[TBL] [Abstract][Full Text] [Related]
2. Label-free quantitative proteomics reveals aberrant expression levels of LRG, C9, FN, A1AT and AGP1 in the plasma of patients with colorectal cancer.
Verathamjamras C; Chantaraamporn J; Sornprachum T; Mutapat P; Chokchaichamnankit D; Mingkwan K; Luevisadpibul V; Srisomsap C; Chutipongtanate S; Svasti J; Champattanachai V
Clin Proteomics; 2023 Apr; 20(1):15. PubMed ID: 37024778
[TBL] [Abstract][Full Text] [Related]
3. A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry.
Zheng X; Xu K; Zhou B; Chen T; Huang Y; Li Q; Wen F; Ge W; Wang J; Yu S; Sun L; Zhu L; Liu W; Gao H; Yue L; Cai X; Zhang Q; Ruan G; Zhu T; Wu Z; Zhu Y; Shao Y; Guo T; Zheng S
J Extracell Vesicles; 2020; 9(1):1750202. PubMed ID: 32363013
[No Abstract] [Full Text] [Related]
4. A proteomic classifier panel for early screening of colorectal cancer: a case control study.
Hua H; Wang T; Pan L; Du X; Xia T; Fa Z; Gu L; Gao F; Yu C; Gao F; Liao L; Shen Z
J Transl Med; 2024 Feb; 22(1):188. PubMed ID: 38383428
[TBL] [Abstract][Full Text] [Related]
5. Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray.
Murakoshi Y; Honda K; Sasazuki S; Ono M; Negishi A; Matsubara J; Sakuma T; Kuwabara H; Nakamori S; Sata N; Nagai H; Ioka T; Okusaka T; Kosuge T; Shimahara M; Yasunami Y; Ino Y; Tsuchida A; Aoki T; Tsugane S; Yamada T
Cancer Sci; 2011 Mar; 102(3):630-8. PubMed ID: 21199170
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis.
Sethi MK; Thaysen-Andersen M; Kim H; Park CK; Baker MS; Packer NH; Paik YK; Hancock WS; Fanayan S
J Proteomics; 2015 Aug; 126():54-67. PubMed ID: 26054784
[TBL] [Abstract][Full Text] [Related]
7. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
[TBL] [Abstract][Full Text] [Related]
9. Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer.
Thorsen SF; Gromova I; Christensen IJ; Fredriksson S; Andersen CL; Nielsen HJ; Stenvang J; Moreira JMA
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810358
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer.
Suman S; Basak T; Gupta P; Mishra S; Kumar V; Sengupta S; Shukla Y
J Proteomics; 2016 Oct; 148():183-93. PubMed ID: 27498393
[TBL] [Abstract][Full Text] [Related]
11. Clinical Assay for the Early Detection of Colorectal Cancer Using Mass Spectrometric Wheat Germ Agglutinin Multiple Reaction Monitoring.
Tsai IJ; Su EC; Tsai IL; Lin CY
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34063271
[TBL] [Abstract][Full Text] [Related]
12. Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
Fijneman RJ; de Wit M; Pourghiasian M; Piersma SR; Pham TV; Warmoes MO; Lavaei M; Piso C; Smit F; Delis-van Diemen PM; van Turenhout ST; Terhaar sive Droste JS; Mulder CJ; Blankenstein MA; Robanus-Maandag EC; Smits R; Fodde R; van Hinsbergh VW; Meijer GA; Jimenez CR
Clin Cancer Res; 2012 May; 18(9):2613-24. PubMed ID: 22351690
[TBL] [Abstract][Full Text] [Related]
13. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development.
Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL
Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884
[No Abstract] [Full Text] [Related]
14. Mass Spectrometry Proteomics Characterization of Plasma Biomarkers for Colorectal Cancer Associated With Inflammation.
Urbiola-Salvador V; Jabłońska A; Miroszewska D; Kamysz W; Duzowska K; Drężek-Chyła K; Baber R; Thieme R; Gockel I; Zdrenka M; Śrutek E; Szylberg Ł; Jankowski M; Bała D; Zegarski W; Nowikiewicz T; Makarewicz W; Adamczyk A; Ambicka A; Przewoźnik M; Harazin-Lechowska A; Ryś J; Macur K; Czaplewska P; Filipowicz N; Piotrowski A; Dumanski JP; Chen Z
Biomark Insights; 2024; 19():11772719241257739. PubMed ID: 38911905
[TBL] [Abstract][Full Text] [Related]
15. Co-expression Network Analysis Identified Key Proteins in Association With Hepatic Metastatic Colorectal Cancer.
Yang W; Shi J; Zhou Y; Liu T; Li J; Hong F; Zhang K; Liu N
Proteomics Clin Appl; 2019 Nov; 13(6):e1900017. PubMed ID: 31397080
[TBL] [Abstract][Full Text] [Related]
16. Fucosylated glycoproteomic approach to identify a complement component 9 associated with squamous cell lung cancer (SQLC).
Narayanasamy A; Ahn JM; Sung HJ; Kong DH; Ha KS; Lee SY; Cho JY
J Proteomics; 2011 Nov; 74(12):2948-58. PubMed ID: 21840429
[TBL] [Abstract][Full Text] [Related]
17. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma.
Hongsachart P; Huang-Liu R; Sinchaikul S; Pan FM; Phutrakul S; Chuang YM; Yu CJ; Chen ST
Electrophoresis; 2009 Apr; 30(7):1206-20. PubMed ID: 19294700
[TBL] [Abstract][Full Text] [Related]
18. Detection of cadherin-17 in human colon cancer LIM1215 cell secretome and tumour xenograft-derived interstitial fluid and plasma.
Bernhard OK; Greening DW; Barnes TW; Ji H; Simpson RJ
Biochim Biophys Acta; 2013 Nov; 1834(11):2372-9. PubMed ID: 23557862
[TBL] [Abstract][Full Text] [Related]
19. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
20. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
